Cargando…
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study
Azathioprine-induced pancreatitis is an idiosyncratic and unpredictable response, occurring in up to 7% of azathioprine-exposed patients with inflammatory bowel disease (IBD). The haplotype HLADQA1-HLADRB1*07:01A>C is strongly associated with azathioprine-induced pancreatitis in IBD. We aimed to...
Autores principales: | Wilson, Aze, Wang, Qian, Choi, Yun-Hee, Ponich, Terry, Gregor, James C., Chande, Nilesh, Yan, Brian, Sey, Michael, Beaton, Melanie, Kim, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345912/ https://www.ncbi.nlm.nih.gov/pubmed/33821842 http://dx.doi.org/10.14309/ctg.0000000000000332 |
Ejemplares similares
-
High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists
por: Guo, Angela, et al.
Publicado: (2022) -
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study
por: Wilson, Aze, et al.
Publicado: (2021) -
Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study
por: Kwapisz, Lukasz, et al.
Publicado: (2015) -
Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?
por: Wilson, Aze, et al.
Publicado: (2014) -
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)